Cerebrospinal fluid hypocretin-1 levels during the active period of cluster headache

Sabina Cevoli, Fabio Pizza, Daniela Grimaldi, Marianna Nicodemo, Valentina Favoni, Giulia Pierangeli, Philipp O. Valko, Christian R. Baumann, Pasquale Montagna, Claudio L. Bassetti, Pietro Cortelli

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Background: Hypocretins (orexins) are hypothalamic neuropeptides which are involved in a wide range of physiological processes in mammals including central pain processing. Genetic studies in humans evidenced a role for the hypocretinergic system in cluster headache (CH).Patients and methods: We tested cerebrospinal fluid (CSF) hypocretin-1 (orexin-A) levels in 10 CH patients during an active cluster period. CSF hypocretin-1 levels were measured by radioimmunoassay.Results: CSF hypocretin-1 levels were within the normal range (mean 457.3-±-104.98-pg/ml, range 304-639) in our 10 patients, with a slight reduction in one case (304-pg/ml). There were no associations between CSF hypocretin-1 levels and the clinical features of CH. A trend towards higher hypocretin-1 levels was disclosed in patients with chronic CH compared to episodic CH.Conclusions: CSF hypocretin-1 levels seem not to influence the clinical course of CH, but our results cannot completely exclude a functional involvement of the hypothalamic hypocretinergic system in the pathogenesis of CH.

Original languageEnglish
Pages (from-to)973-976
Number of pages4
JournalCephalalgia
Volume31
Issue number8
DOIs
Publication statusPublished - Jun 2011

Fingerprint

Cluster Headache
Cerebrospinal Fluid
Physiological Phenomena
Orexins
Neuropeptides
Radioimmunoassay
Mammals
Reference Values
Pain

Keywords

  • Cluster headache
  • hypocretin-1
  • hypothalamus
  • orexin

ASJC Scopus subject areas

  • Clinical Neurology

Cite this

Cerebrospinal fluid hypocretin-1 levels during the active period of cluster headache. / Cevoli, Sabina; Pizza, Fabio; Grimaldi, Daniela; Nicodemo, Marianna; Favoni, Valentina; Pierangeli, Giulia; Valko, Philipp O.; Baumann, Christian R.; Montagna, Pasquale; Bassetti, Claudio L.; Cortelli, Pietro.

In: Cephalalgia, Vol. 31, No. 8, 06.2011, p. 973-976.

Research output: Contribution to journalArticle

Cevoli, S, Pizza, F, Grimaldi, D, Nicodemo, M, Favoni, V, Pierangeli, G, Valko, PO, Baumann, CR, Montagna, P, Bassetti, CL & Cortelli, P 2011, 'Cerebrospinal fluid hypocretin-1 levels during the active period of cluster headache', Cephalalgia, vol. 31, no. 8, pp. 973-976. https://doi.org/10.1177/0333102411403634
Cevoli, Sabina ; Pizza, Fabio ; Grimaldi, Daniela ; Nicodemo, Marianna ; Favoni, Valentina ; Pierangeli, Giulia ; Valko, Philipp O. ; Baumann, Christian R. ; Montagna, Pasquale ; Bassetti, Claudio L. ; Cortelli, Pietro. / Cerebrospinal fluid hypocretin-1 levels during the active period of cluster headache. In: Cephalalgia. 2011 ; Vol. 31, No. 8. pp. 973-976.
@article{8eb61a8657814874a76a49c076911513,
title = "Cerebrospinal fluid hypocretin-1 levels during the active period of cluster headache",
abstract = "Background: Hypocretins (orexins) are hypothalamic neuropeptides which are involved in a wide range of physiological processes in mammals including central pain processing. Genetic studies in humans evidenced a role for the hypocretinergic system in cluster headache (CH).Patients and methods: We tested cerebrospinal fluid (CSF) hypocretin-1 (orexin-A) levels in 10 CH patients during an active cluster period. CSF hypocretin-1 levels were measured by radioimmunoassay.Results: CSF hypocretin-1 levels were within the normal range (mean 457.3-±-104.98-pg/ml, range 304-639) in our 10 patients, with a slight reduction in one case (304-pg/ml). There were no associations between CSF hypocretin-1 levels and the clinical features of CH. A trend towards higher hypocretin-1 levels was disclosed in patients with chronic CH compared to episodic CH.Conclusions: CSF hypocretin-1 levels seem not to influence the clinical course of CH, but our results cannot completely exclude a functional involvement of the hypothalamic hypocretinergic system in the pathogenesis of CH.",
keywords = "Cluster headache, hypocretin-1, hypothalamus, orexin",
author = "Sabina Cevoli and Fabio Pizza and Daniela Grimaldi and Marianna Nicodemo and Valentina Favoni and Giulia Pierangeli and Valko, {Philipp O.} and Baumann, {Christian R.} and Pasquale Montagna and Bassetti, {Claudio L.} and Pietro Cortelli",
year = "2011",
month = "6",
doi = "10.1177/0333102411403634",
language = "English",
volume = "31",
pages = "973--976",
journal = "Cephalalgia",
issn = "0333-1024",
publisher = "SAGE Publications Ltd",
number = "8",

}

TY - JOUR

T1 - Cerebrospinal fluid hypocretin-1 levels during the active period of cluster headache

AU - Cevoli, Sabina

AU - Pizza, Fabio

AU - Grimaldi, Daniela

AU - Nicodemo, Marianna

AU - Favoni, Valentina

AU - Pierangeli, Giulia

AU - Valko, Philipp O.

AU - Baumann, Christian R.

AU - Montagna, Pasquale

AU - Bassetti, Claudio L.

AU - Cortelli, Pietro

PY - 2011/6

Y1 - 2011/6

N2 - Background: Hypocretins (orexins) are hypothalamic neuropeptides which are involved in a wide range of physiological processes in mammals including central pain processing. Genetic studies in humans evidenced a role for the hypocretinergic system in cluster headache (CH).Patients and methods: We tested cerebrospinal fluid (CSF) hypocretin-1 (orexin-A) levels in 10 CH patients during an active cluster period. CSF hypocretin-1 levels were measured by radioimmunoassay.Results: CSF hypocretin-1 levels were within the normal range (mean 457.3-±-104.98-pg/ml, range 304-639) in our 10 patients, with a slight reduction in one case (304-pg/ml). There were no associations between CSF hypocretin-1 levels and the clinical features of CH. A trend towards higher hypocretin-1 levels was disclosed in patients with chronic CH compared to episodic CH.Conclusions: CSF hypocretin-1 levels seem not to influence the clinical course of CH, but our results cannot completely exclude a functional involvement of the hypothalamic hypocretinergic system in the pathogenesis of CH.

AB - Background: Hypocretins (orexins) are hypothalamic neuropeptides which are involved in a wide range of physiological processes in mammals including central pain processing. Genetic studies in humans evidenced a role for the hypocretinergic system in cluster headache (CH).Patients and methods: We tested cerebrospinal fluid (CSF) hypocretin-1 (orexin-A) levels in 10 CH patients during an active cluster period. CSF hypocretin-1 levels were measured by radioimmunoassay.Results: CSF hypocretin-1 levels were within the normal range (mean 457.3-±-104.98-pg/ml, range 304-639) in our 10 patients, with a slight reduction in one case (304-pg/ml). There were no associations between CSF hypocretin-1 levels and the clinical features of CH. A trend towards higher hypocretin-1 levels was disclosed in patients with chronic CH compared to episodic CH.Conclusions: CSF hypocretin-1 levels seem not to influence the clinical course of CH, but our results cannot completely exclude a functional involvement of the hypothalamic hypocretinergic system in the pathogenesis of CH.

KW - Cluster headache

KW - hypocretin-1

KW - hypothalamus

KW - orexin

UR - http://www.scopus.com/inward/record.url?scp=79958816224&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79958816224&partnerID=8YFLogxK

U2 - 10.1177/0333102411403634

DO - 10.1177/0333102411403634

M3 - Article

C2 - 21444644

AN - SCOPUS:79958816224

VL - 31

SP - 973

EP - 976

JO - Cephalalgia

JF - Cephalalgia

SN - 0333-1024

IS - 8

ER -